Craneware (LON:CRW) Shares Down 25.6% Following Analyst Downgrade

Craneware plc (LON:CRW)’s share price fell 25.6% during trading on Monday after Berenberg Bank lowered their price target on the stock from GBX 2,600 to GBX 1,600. Berenberg Bank currently has a buy rating on the stock. Craneware traded as low as GBX 993 and last traded at GBX 998. 6,316,417 shares traded hands during mid-day trading, an increase of 725% from the average daily volume of 765,522 shares. The stock had previously closed at GBX 1,342.

Insider Buying and Selling at Craneware

In other news, insider Will Whitehorn purchased 640 shares of Craneware stock in a transaction dated Friday, July 3rd. The stock was purchased at an average cost of GBX 1,173 per share, for a total transaction of £7,507.20. Also, insider Keith Neilson bought 9,074 shares of Craneware stock in a transaction that occurred on Monday, July 6th. The shares were acquired at an average price of GBX 1,102 per share, with a total value of £99,995.48. 10.32% of the stock is owned by company insiders.

Craneware Stock Performance

The company has a 50 day simple moving average of GBX 1,276.30 and a 200-day simple moving average of GBX 1,371.04. The company has a debt-to-equity ratio of 7.93, a current ratio of 0.76 and a quick ratio of 1.00. The stock has a market cap of £341.69 million, a P/E ratio of 15.87 and a beta of 0.28.

Craneware Company Profile

For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster – that simplify the complexities of healthcare finance and operations.